Daniel Camus

Daniel J.
Camus is currently Director at Foundation for Innovative New Diagnostics, Director at MedAccess Guarantee Ltd., and Member-Management Board at Hoechst Marion Roussel AG.
Former roles include Chairman at EDF International SAS, EDF Energy Ltd., and EDF Energy Group Holdings Plc; Director at Constellation Energy Group, Inc. in 2010; Independent Non-Executive Director at Valeo SE from 2006 to 2018; Director at Edison SpA from 2005 to 2009; Director at EnBW Energie Baden Württemberg AG from 2003 to 2010; Director at Transalpina di Energia SpA; Director at EDF Energy (UK) Ltd.; Independent Non-Executive Director at Cameco Corp.
from 2011 to 2026; Independent Non-Executive Director at ContourGlobal Ltd. from 2016 to 2022; Member-Supervisory Board at SGL Carbon SE from 2008 to 2018; Member-Supervisory Board at Vivendi SE from 2013 to 2015; Group CFO, Head-Strategy & International at Électricité de France SA from 2002 to 2011; Member-Supervisory Board at MorphoSys AG from 2003 to 2015; Member-Supervisory Board at Veolia Services Energetiques SAS; Chief Financial Officer at Roussel Uclaf SA; Senior Advisor at Roland Berger GmbH; Chief Financial Officer at Aventis Pharma AG; Chief Financial Officer at The Global Fund to Fight AIDS, Tuberculosis & Malaria from 2012 to 2017; Chief Financial Officer at Hoechst Marion Roussel, Inc.; Vice President & GM-Industrial Chemicals Division at Hoechst Marion Roussel Canada, Inc.; Chief Financial Officer at Polymedic SA; Chief Financial Officer at Hoechst Maroc; VP & General Manager-Industrial Chemicals Division at Hoechst Canada, Inc. Education includes an MBA from Sciences Po in 1975, a graduate degree from Nancy-Université in 1974, and a doctorate from Sorbonne Université.